Thornberry Nancy — SEC insider filings
SEC reporting owner CIK 1797826. 21 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-01-12 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 32,239 shares, $1,502,788 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: sale of 1,000 shares @ $547.86 ($547,860) in VERTEX PHARMACEUTICALS INC / MA, filed 2026-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Schrodinger, Inc. (SDGR) | Director | 8 | — | 2 legs · 19,800 sh · $693,000 | 14 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | 5 | — | 1 leg · 1,000 sh · $547,860 | 9 |
| Denali Therapeutics Inc. (DNLI) | Director | 8 | — | 2 legs · 11,439 sh · $261,929 | 13 |
Insider filings — Thornberry Nancy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,000 @ $547.86 | EDGAR |
| 2026-09-04 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 10,824 @ $22.85 · Sale (S): 615 @ $23.74 | EDGAR |
| 2026-06-23 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 472 @ $0 · Disposition to issuer (D): 398 · Grant/award (A): 1,433 (derivative) @ $0 · Grant/award (A): 398 (derivative) | EDGAR |
| 2025-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 398 @ $0 · Grant/award (A): 1,199 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 8,550 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 5,967 @ $0 · Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 501 @ $0 · Grant/award (A): 1,571 (derivative) @ $0 | EDGAR |
| 2023-12-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 1,136 @ $0 | EDGAR |
| 2023-06-16 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-06-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 4,216 @ $0 · Grant/award (A): 12,649 (derivative) @ $0 | EDGAR |
| 2023-05-23 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 14,850 @ $11.52 · Sale (S): 14,850 @ $35 · Option exercise (M): 14,850 (derivative) @ $0 | EDGAR |
| 2022-08-12 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 4,950 @ $11.52 · Sale (S): 4,950 @ $35 · Option exercise (M): 4,950 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 14,907 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 5,986 @ $0 · Grant/award (A): 17,959 (derivative) @ $0 | EDGAR |
| 2022-01-11 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 627 @ $0 | EDGAR |
| 2021-06-21 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 8,736 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 7,535 (derivative) @ $0 · Grant/award (A): 2,511 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs